D
Portage Biotech Inc. PRTG
$5.42 -$0.54-9.06% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Net Income 91.02% 79.45% 40.47% 34.67% 27.98%
Total Depreciation and Amortization -35.19% -7.32% 59.26% 325.00% 5,300.00%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -100.41% -83.43% -41.11% -40.13% -35.16%
Change in Net Operating Assets 54.58% 885.59% -62.67% 1,454.17% 9,920.00%
Cash from Operations 61.80% 52.86% 35.24% 6.14% -18.42%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- 557.98% 557.98%
Cash from Investing -- -- -- 555.75% 555.75%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -17.50% -60.71% -147.06% 97.91% 98.00%
Issuance of Common Stock -64.27% -86.89% 45.72% 49.11% 101.88%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- 109.30% 107.27% 100.63% 98.91%
Cash from Financing -64.75% -87.16% 49.99% 994.89% 5,200.85%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 39.13% 53.32% 85.50% 67.62% 56.92%